Aviv Regev

Dr. Aviv Regev is Executive Vice President of Research and a member of the extended Corporate Executive Committee of Roche. She is the Founding Co-Chair of the international Human Cell Atlas project and a Professor of Biology at MIT (currently on leave). Previously she was a Core Institute Member, Chair of the Faculty, and Director of the Klarman Cell Observatory at the Broad Institute of MIT and Harvard, where she also co-directed the Cell Circuits Program. She is formerly a Howard Hughes Medical Institute Investigator.

Dr. Regev’s pioneering work has been recognized by the inaugural FASEB Excellence in Science Mid-Career Investigator Award, the Paul Marks Prize, and the Innovator Award and Overton Prize from the International Society for Computational Biology. In addition, she is an elected member of the National Academy of Sciences.

Dr. Regev received her MSc from Tel Aviv University, studying biology, computer science, and mathematics in the Adi Lautman Interdisciplinary Program for the Fostering of Excellence. She received her PhD in computational biology, also from Tel Aviv University.